Welcome back to Invested Early.

The humanoid robot era just got its stock market debut. Agility Robotics announced a $2.5 billion SPAC merger with Churchill Capital, making it the first pure-play humanoid company headed for a major exchange. An AI biotech spiked 36% after Eli Lilly backed its $100 million raise. And the SpaceX proxy trade is unwinding fast, with Velo3D down 30% in two days. We're covering all three, plus a look at the specific sectors where small caps have the most room to run.

Here's what's inside today:

🎯 Where small caps shine: the sectors with asymmetric upside
🤖 The $2.5 billion humanoid robot company going public this week
📊 What alternative data actually looks like (and why it matters)
📈 Top gainers (and biggest losers) yesterday

And this uranium company just might push the US’s AI energy narrative forward.

Let’s get into it!

This is not financial advice. Always do your own research. Past performance doesn't guarantee future results.

Not all corners of the market treat small caps the same. Some sectors actively punish companies without scale, while others reward them for it.

Biotech is the classic example. A single FDA approval or trial readout can move a stock 50%, 100%, or more in a session. This week Absci (ABSI) jumped 35% after posting positive Phase 1 data for an AI-designed drug and pricing a $100 million raise with Eli Lilly. Big pharma can't achieve that upside because their base is too large for any single catalyst to move the needle.

Mining and critical minerals work the same way. A junior explorer with a promising deposit can 10x if the resource proves out. A major like Rio Tinto barely budges on the same news.

Robotics and AI hardware are newer to this list. Agility Robotics is going public at $2.5 billion, backed by Nvidia, Amazon, and SoftBank. The humanoid market barely exists yet, but companies small enough to capture early wins can see valuations double or triple.

Space and fintech round out the group. Both reward first movers with outsized returns when timing aligns.

The common thread: these are sectors where a single catalyst can reprice an entire company overnight. That's where small-cap math can work in your favor.

Agility Robotics just became the first pure-play humanoid company headed for a major U.S. exchange. If you've been waiting for a way to bet on robots in the workforce, this is the opening.

The news: Agility announced a definitive merger agreement with Churchill Capital Corp XI (CCXI) at a $2.5 billion pre-money valuation. The combined company will trade under the ticker AGLT once the deal closes later this year. The transaction includes about $420 million from Churchill's trust plus a $200 million PIPE (private investment in public equity) at $10 per share, led by Foxconn with participation from Nvidia and other existing investors.

Why it matters: Agility isn't a concept company. Its Digit robot is already operating in live commercial environments at Schaeffler, GXO, Toyota Motor Manufacturing Canada, and Mercado Libre. The company has logged over 65,000 hours of real-world operation and has more than $300 million in contracted orders for its next-generation Digit v5. Nvidia selected Agility as the launch partner for its Halos safety system, which tells you where the industry sees the technology going.

The bull case is straightforward: labor shortages are real, humanoids are finally capable enough to do repetitive physical work, and Agility has a head start on commercial deployment. Management estimates the addressable market across manufacturing, distribution, and logistics at roughly $1 trillion.

The risk: Agility has no revenue. The company is pre-commercial, burning cash, and now facing the typical post-SPAC scrutiny where valuations often compress after the merger closes. Humanoid robotics is a crowded field with well-funded competitors including Tesla's Optimus and Figure AI. The $2.5 billion valuation is a bet on execution, not current earnings. If Digit v5 deployments slip or customers walk, the stock won't be forgiving.

Our partners at AltIndex track signals most investors never see. We talk about "alternative data" a lot in this newsletter, so here's what that actually means in practice.

They're pulling job postings (a proxy for growth or slowdown), Reddit mentions in real time, LinkedIn employee counts, 4chan chatter, X mentions, news coverage, and employee sentiment from sites like Glassdoor. Each signal updates daily or monthly depending on the source.

The idea is simple: by the time earnings come out, the market has already priced in the news. But if you can see a company ramping up hiring three months before the earnings call, or watch Reddit mentions spike before a stock goes viral, you're working with information that hasn't hit the price yet.

Explore the full dataset →

Here's where yesterday’s biggest moves landed.

Wendy's is the headline on the gainer side: WallStreetBets lit up the stock, trading was halted at one point, and it closed up nearly 26% on a new CFO hire and meme momentum. Absci held its gains after posting Phase 1 data and pricing a $100 million raise with Eli Lilly. On the loser side, Hertz had its worst day ever after announcing a $100 million stock offering and slashing Q2 guidance. Velo3D extended its two-day selloff to 30% as the SpaceX proxy trade continues to unwind.

(Data: Yahoo Finance.)

Yesterday brought a $2.5 billion humanoid robot SPAC, an AI biotech spiking 36% on Phase 1 data and an Eli Lilly check, and a SpaceX proxy trade unwinding to the tune of 30% losses. The sectors where small caps shine are also the sectors where they fall hardest. We'll keep showing you both sides.

Watching a name we should cover? Hit reply and tell us.

Cheers,
— Brandon & Blake of Invested Inc.